首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 171 毫秒
1.
目的:观察盐酸格拉司琼在体外对大肠埃希菌、金黄色葡萄球菌、铜绿假单胞菌抑菌作用的影响。方法:将盐酸格拉司琼注射液用无菌生理盐水稀释至终浓度分别为0.5、0.25、0.125和0.0 625mg/mL,与大肠埃希杆菌、金黄色葡萄球菌、和铜绿假单胞菌培养,每个实验重复三遍,所有菌株的稀释的系列测定均进行两次。结果:格拉司琼对大肠埃希菌、金黄色葡萄球菌、铜绿假单胞菌均有明显的抑菌作用,格拉司琼对大肠埃希菌的抑菌作用随着格拉司琼浓度的增加而增加,至0.0 625mg/mL时仍有明显的抑菌作用(P<0.05)。格拉司琼对金黄色葡萄球菌和铜绿假单胞菌的抑菌作用在格拉司琼浓度为0.125mg/mL时消失。结论:格拉司琼在体外可以抑制大肠埃希菌、金黄色葡萄球菌、铜绿假单胞菌的生长,对于预防麻醉相关的感染可能有一定的临床意义。  相似文献   

2.
《中国医学创新》2015,(30):118-121
目的:研究以壳聚糖磷酸降解产物制作妇科医用辅料的抑菌效果。方法:利用磷酸降解壳聚糖得到磷酸降解产物并制作成壳聚糖磷酸降解产物衍生敷料,测定磷酸降解产物对标准菌株的最小抑菌浓度并检验壳聚糖磷酸降解产物衍生敷料的抑菌性。结果:壳聚糖磷酸降解产物对金黄色葡萄球菌、大肠埃希菌和白色念珠菌的最小抑菌浓度分别为0.25、0.25、0.5 mg/m L;栓剂敷料和水凝胶敷料对金黄色葡萄球菌、大肠埃希菌及白色念珠菌的抑菌环直径分别为13、13、11 mm和14、14、12 mm。结论:壳聚糖磷酸降解产物具有强大的广谱抗菌性能,可以在制作妇科医用敷料中推广应用。  相似文献   

3.
目的:利用静电纺丝技术制备纳米纤维敷料,并研究其抗菌效果。方法:采用聚丙烯腈(PAN)为前驱体高分子,利用静电纺丝技术及高温碳化方法制备碳纳米纤维敷料,并通过银镜反应制备纳米银/碳纳米纤维复合敷料。将2种样本与庆大霉素纸片及优拓(urgotul)敷料采用Kirby-Baucer法进行体外抑菌实验。结果:成功制备出具有纳米级支架结构且负载纳米银的的创面敷料。体外抑菌实验结果显示,纳米银/碳纳米纤维复合敷料和优拓对金黄色葡萄球菌、铜绿假单胞菌和大肠埃希菌标准菌株均有较好的抑菌效果;纳米银/碳纳米纤维复合敷料对于金黄色葡萄球菌及铜绿假单胞菌抑菌效果优于优拓,但对大肠杆菌的抑制效果低于优拓;碳纳米纤维未显示出具有抑菌能力。结论:纳米银/碳纳米纤维复合敷料具有纳米级支架结构,是具有较好抗菌能力的烧伤创面敷料。  相似文献   

4.
目的:研究南特桉(NTA)的体外抗菌能力。方法:测定67株临床分离耐药菌株的MIC值和3株标准菌株(大肠埃希氏菌ATCC 25922,金黄色葡萄球菌ATCC 25923,铜绿假单胞菌 ATCC 27853)的时间-杀菌曲线。结果:南特桉的抑菌能力随菌种不同而有差异,对金黄色葡萄球菌、铜绿假单胞菌、肠杆菌科细菌、其它菌的MIC50分别为1.708,3.217,8.123,87.222 mg/ml,MIC90分别为5.946,4.578,69.631,141.685mg/ml。总的MIC范围为0.625-80mg/ml。时间-杀菌曲线的结果表明NTA能分别在30,5,5min内完全杀灭金黄色葡萄球菌、铜绿假单胞菌和大肠埃希氏菌。结论:南特桉具有广谱抗菌作用,不仅能抑制多种耐药菌株的生长,还有杀菌能力,在烧伤治疗中具有较大的开发和应用前景。  相似文献   

5.
目的:测定芸香草等22种中草药提取物体外抑菌活性。方法:乙醇冷浸制备22种植物药材的乙醇提取物,观察其对金黄色葡萄球菌、大肠埃希菌、白念珠菌、铜绿假单胞菌及耐甲氧西林金黄色葡萄球菌(MRSA)的抑制作用,用琼脂打孔法对其抗菌活性进行筛选,通过倍比稀释法测定其最低抑菌浓度(MIC)和最低杀菌浓度(MBC)。结果:22种乙醇提取物中有6种对金黄色葡萄球菌、大肠埃希菌、白念珠菌、铜绿假单胞菌有不同程度的抑制作用,有7种对MRSA有较强的抑制作用,抑菌圈直径为15~27 mm,MIC为31.25~500 mg/L,MBC为250~2 000 mg/L,对白念珠菌、大肠埃希菌活性较弱。结论:芸香草、肉豆蔻等7种对所测金黄色葡萄球菌及MRSA具有较好的抑菌效果。  相似文献   

6.
目的:研究头花蓼不同极性部位对引起泌尿系统感染等细菌的抑菌效果。方法:采用K-B纸片法,分别测定从头花蓼70%乙醇提取物中分离的7个不同极性部位的样品(A-G)对大肠埃希菌、铜绿假单胞杆菌、枯草杆菌、金黄色葡萄球菌、变形杆菌、粪肠球菌的敏感度;用液体稀释法测定A-G的最低抑菌浓度(MIC)和最低杀菌浓度(MBC)。结果:头花蓼7个极性部位(A-G)均对大肠埃希菌、铜绿假单胞杆菌、变形杆菌的敏感度较高,而对金黄色葡萄球菌、粪肠球菌敏感度低;A-G七个对大肠埃希菌、铜绿假单胞杆菌的最低和最大MBC、MIC浓度分别为0.78、6.25 mg/m L,1.56、3.12 mg/m L;0.20、3.12 mg/m L,0.39、3.12mg/m L。结论:头花蓼不同极性部位对大肠埃希菌和铜绿假单胞杆菌均具有较高的抑菌活性,抑菌强弱分别为A﹥B﹥C=D=F﹥E=G;B=C=D﹥A=F=G﹥E。  相似文献   

7.
目的:观察五黄膏的抑菌作用。方法:制备五黄膏制剂,取样进行细菌培养和抑菌实验,以凡士林为对照,观察五黄膏对标准菌株和临床菌株(金黄色葡萄球菌、大肠埃希氏菌、铜绿假单胞菌)抑菌作用。结果:五黄膏制剂取样培养无细菌生长,抑菌实验证实其对金黄色葡萄球菌、大肠埃希氏菌、铜绿假单胞菌标准菌株均具有明显抑菌作用,与对照组比较,差异有统计学意义(P<0.01);对金黄色葡萄球菌、大肠埃希氏菌、铜绿假单胞菌临床菌株有显著抑菌作用(P<0.01)。结论:五黄膏体外对标准菌株和临床菌株(金黄色葡萄球菌、大肠埃希氏菌、铜绿假单胞菌)具有抑菌作用。  相似文献   

8.
目的探讨厚朴不同部位的体外抑菌活性。方法制备厚朴不同部位的水提物溶液;利用试管稀释法测定上述溶液对金黄色葡萄球菌、大肠埃希菌和铜绿假单胞菌的最低抑菌浓度(MIC)。结果厚朴(皮)作用最好,厚朴果实活性较低,厚朴叶居两者之间。其中厚朴(皮)对大肠埃希菌作用最强,MIC=0.125g/m L,对金黄色葡萄球菌MIC=0.25g/m L,对铜绿假单胞菌MIC=1g/m L;厚朴果实水提物在1g/m L的浓度下对金黄色葡萄球菌有一定的抑菌作用;厚朴叶水提物在1g/m L的浓度下对3种供试菌均有抑制作用。结论厚朴不同部位都有一定的抑菌活性。  相似文献   

9.
目的:观察肺感方对11种临床常见病原菌的体外抗菌作用.方法:使用肉汤微量稀释法测定肺感方对不同菌株的最低抑菌浓度(MIC)及最低杀菌浓度(MBC).结果:肺感方对标准金黄色葡萄球菌、铜绿假单胞菌、大肠埃希菌、肺炎克雷伯菌、阴沟肠球菌、铅黄肠球菌的MIC分别为62.5,62.5,125,31.25,250,500 g/L,相应的MBC为:62.5,62.5,250,31.25,500,1 000 g/L;对临床分离菌株鲍曼不动杆菌(多重耐药)、铜绿假单胞菌(多重耐药)的MIC和MBC均分别为250,500 g/L;对粪肠球菌、白色念珠菌、肺炎克雷伯菌(超广谱β内酰胺酶阳性)、大肠埃希菌(超广谱β内酰胺酶阳性)无明显体外抗菌作用.结论:肺感方对金黄色葡萄球菌、铜绿假单胞菌、大肠埃希菌、肺炎克雷伯菌、阴沟肠杆菌、铅黄肠球菌、鲍曼不动杆菌(多重耐药)及铜绿假单胞菌(多重耐药)具有体外抗菌作用,其中对肺炎克雷伯菌的抗菌活性最强.  相似文献   

10.
目的:考察妇科活血止痛颗粒的体外抑菌作用.方法:采用双倍稀释法,以妇乐颗粒为对照药,测定妇科活血止痛颗粒对金黄色葡萄球菌、大肠埃希菌、铜绿假单胞菌、乙型溶血性链球菌、白色念珠菌的体外最低抑菌浓度(MIC).结果:妇科活血止痛颗粒对金黄色葡萄球菌、大肠埃希菌、乙型溶血性链球菌、白色念珠菌的体外抑菌作用较强,对铜绿假单胞菌的体外抑菌作用稍弱.结论:妇科活血止痛颗粒对金黄色葡萄球菌、大肠埃希菌、铜绿假单胞菌、乙型溶血性链球菌、白色念珠菌均具有良好的体外抑菌作用,且效果优于妇乐颗粒.  相似文献   

11.
羧甲基壳聚糖的制备及抑菌作用的研究   总被引:9,自引:0,他引:9  
目的:研究羧甲基壳聚糖的合成反应及其抑菌活性.方法:用化学方法修饰壳聚糖,用稀释法对常见病原菌进行抑菌实验.结果:产物经红外光谱证实,壳聚糖已被氯乙酸所修饰,产物对金黄色葡萄球菌、大肠杆菌、绿脓杆菌均有抑菌作用.结论:本法制得的羧甲基壳聚糖具有优越的水溶性能,对常见致病菌有一定的抑菌活性.  相似文献   

12.
Objective The objective of this study was to investigate arsenic induced changes in blood δ-aminolevulinic acid dehydratase (ALAD) after in vitro and in vivo exposure to this element and its response to co-administration of meso 2,3-dimercaptosuccinic acid (DMSA) and monoisoamyl DMSA (MiADMSA) either individually or in combination. Methods Rat whole blood was exposed to varying concentrations (0.1, 0.2 and 0.5 mmol/L) of arsenic (Ⅲ) or arsenic (V), to assess their effects on blood ALAD activity. Varying concentrations of MiADMSA and DMSA (0.1, 0.5 and 1.0 mmol/L) were also tried in combination to determine its ability to mask the effect of arsenic induced (0.5 mmol/L) inhibition of blood ALAD in vitro. In vitro and in vivo experiments were also conducted to determine the effects of DMSA and MiADMSA either individually or in combination with arsenic, on blood ALAD activity and blood arsenic concentration. Results In vitro experiments showed significant inhibition of the enzyme activity when 0.1-0.5 mmol/L of arsenic (Ⅲ and V) was used. Treatment with MiADMSA increased ALAD activity when blood was incubated at the concentration of 0.1 mmol/L arsenic (Ⅲ) and 0.1 mmol/L MiADMSA. No effect of 0.1 mmol/L MiADMSA on ALAD activity was noticed when the arsenic concentration was increased to 0.2 and 0.5 mmol/L. Similarly, MiADMSA at a lower concentration (0.1 mmol/L) was partially effective in the turnover of ALAD activity against 0.5 mmol/L arsenic (Ⅲ), but at two higher concentrations (0.5and 1.0 mmol/L) a complete restoration of ALAD activity was observed. DMSA at all the three concentrations (0.1, 0.5 and 1.0 mmol/L) was effective in restoring ALAD activity to the normal value.Conclusions The results thus suggest that arsenic has a distinct effect on ALAD activity. Another important toxicological finding of the present study, based on in vivo experiments further suggests that combined administration of DMSA and MiADMSA could be more beneficial for reducing blood ALAD inhibition and blood arsenic concentration than the individual treatment.  相似文献   

13.
目的:探讨棕榈酸对3T3-L1脂肪细胞内甘油三酯蓄积的影响,建立肥大脂肪细胞模型.方法:分别用0.0、0.1、0.2和0.4mmol/L棕榈酸诱导成熟3T3-L1 48b,用油红O染色法鉴定脂肪细胞,用甘油三酯酶法测定胞内甘油三酯浓度,采用细胞总蛋白浓度对胞内甘油三酯浓度进行校正.结果:0.0、0.1、0.2和0.4 mmol/L棕榈酸组甘油三酯水平分别为(5.0±0.6)、(6.9±1.4)、(5.7±0.5)和(5.6±0.7)μmol/mg,0.1 mmol/L棕榈酸组可引起造模组甘油三酯的浓度增加(P<0.05).结论:0.1 mmol/L棕榈酸能诱导成熟3T3-L1内甘油三酯蓄积.  相似文献   

14.
Objective The objective of this study was to investigate arsenic induced changes in blood δ-aminolevulinic acid dehydratase (ALAD) after in vitro and in vivo exposure to this element and its response to co-administration of meso 2,3-dimercaptosuccinic acid (DMSA) and monoisoamyl DMSA (MiADMSA) either individually or in combination.Methods Rat whole blood was exposed to varying concentrations (0.1, 0.2 and 0.5mmol/L) of arsenic (Ⅲ) or arsenic (Ⅴ),to assess their effects on blood ALAD activity. Varying concentrations of MiADMSA and DMSA (0.1,0.5 and 1.0mmol/L) were also tried in combination to determine its ability to mask the effect of arsenic induced (0.5mmol/L) inhibition of blood ALAD in vitro. In vitro and in vivo experiments were also conducted to determine the effects of DMSA and MiADMSA either individually or in combination with arsenic,on blood ALAD activity and blood arsenic concentlation.Results In vitro experiments showed significant inhibition of the enzyme activity when 0.1-0.5 mmol/L of arsenic (Ⅲ and Ⅴ) was used.Treatment with MiADMSA increased ALAD activity when blood was incubated at the concentration of 0.1mmol/L arsenic (Ⅲ) and 0.1mmol/L MiADMSA. No effect of 0.1mmol/L MiADMSA on ALAD activity was noticed when the arsenic concentration was increased to 0.2 and 0.5 mmol/L. Similarly, MiADMSA at a lower concentration (0.1mmol/L) was partially effective in the turnover of ALAD activity against 0.5 mmol/L arsenic (Ⅲ),but at two higher concentrations (0.5 and 1.0mmol/L) a complete restoration of ALAD activity was observed. DMSA at all the three concentrations (0.1,0.5 and 1.0mmol/L) was effective in restoring ALAD activity to the normal value Conclusions The results thus suggest that arsenic has a distinct effect on ALAD activity.Another important toxicological finding of the present study,based on in vivo experiments further suggests that combined administration of DMSA and MiADMSA could be more beneficial for reducing blood ALAD inhibition and blood arsenic concentration than the individual treatment.  相似文献   

15.
阿司匹林诱导内皮细胞铁蛋白表达与抗氧化损伤作用的研究   总被引:12,自引:0,他引:12  
目的探讨阿司匹林(aspirin,As)在抗H2O2损伤内皮细胞过程中对铁蛋白(ferritin,Fn)表达的作用.方法体外培养人血管内皮细胞,酶联免疫吸附法(ELISA)测定As在不同浓度(0.1~3mmol/L)、不同处理时间(4~24h)对细胞Fn表达的影响,以及消炎痛和水杨酸钠对Fn表达的作用;并观察经As预处理后的细胞加入H2O2(0.5mmol/L)后乳酸脱氢酶(lactatedehydrogenase,LDH)释放率、丙二醛(malondialdehyde,MDA)和细胞存活率的改变.用单因素方差分析对上述指标进行统计学处理.结果小剂量As(0.1mmol/L)即可明显诱导内皮细胞Fn表达(5.8ng/106细胞数±0.3ng/106细胞数),与正常对照组比较P<0.05;且As与Fn之间表现出剂量和时间依赖关系,0.5mmol/L、1mmol/L、2mmol/L、3mmol/L组Fn浓度分别为(6.4±0.4)ng/106细胞数、(7.0±0.7)ng/106细胞数、(7.4±0.4)ng/106细胞数和(7.7±0.5)ng/106细胞数;4h组Fn尚未明显增加(5.8ng/106细胞数±1.0ng/106细胞数,P>0.05),但8h组Fn浓度(6.5±1.0)ng/106细胞数与正常对照组比较P<0.05,24h组Fn浓度达最大值(7.8±0.8)ng/106细胞数.As诱导Fn表达后能明显增强细胞抗氧化的能力,0.1mmol/L的As可减少细胞50%的LDH释放率,保护74.4%的细胞避免H2O2的损伤,同时使氧自由基指标MDA明显下降.并随As剂量的增大保护作用逐渐增强,其结果与未饱和铁蛋白组相似.而水杨酸钠及消炎痛则无诱导Fn表达的作用.结论As在较小剂量(0.1mmol/L)时即可明显诱导内皮细胞Fn的表达,增强其抗氧化损伤的能力;但其他非甾体类抗炎药不具有这个作用.  相似文献   

16.
目的:研究溶菌酶与乙二胺四乙酸二钠( ethylenediaminetetraacetic acid disodium salt ,EDTA二钠)对粪肠球菌和牙髓卟啉单胞菌的协同抑菌作用。方法:分别培养粪肠球菌和牙髓卟啉单胞菌,并调整菌液浓度至108菌落形成单位(colony-forming unit,CFU)/mL;配制终浓度为0.3、0.5、1、2、5、10、50、100、150和300 g/L的单纯溶菌酶抑菌液,以及添加浓度为0.5、1.0、2.0 g/L的EDTA二钠的混合抑菌液。将菌液与抑菌液作用15 min,加入水溶性四唑盐(water-soluble tetrazolium,WST)工作液染色,酶标仪测定光密度值,计算细菌活性。结果:单纯溶菌酶抑菌液(浓度0.5~150 g/L)对两种细菌的抑菌作用随溶菌酶浓度的升高而增强,且对粪肠球菌的抑菌作用更显著。EDTA二钠与溶菌酶有协同抑菌作用,与溶菌酶浓度相关。溶菌酶浓度为0.5~50 g/L时,EDTA二钠协同溶菌酶作用于粪肠球菌(P<0.05),可使其抑菌作用提高约1.2~3.7倍;溶菌酶浓度为0.5~10 g/L时, EDTA二钠协同溶菌酶作用于牙髓卟啉单胞菌(P<0.05),可使其抑菌作用提高约1.3~3.5倍;当溶菌酶浓度大于100 g/L时,加入EDTA二钠对细菌均没有明显的协同抑菌作用(P>0.05)。结论:对于粪肠球菌及牙髓卟啉单胞菌,在溶菌酶较低浓度时,EDTA二钠有协同抑菌作用;在溶菌酶较高浓度时,EDTA二钠无协同抑菌作用。  相似文献   

17.
目的:建立快速、灵敏的LC-MS/MS分析方法定量测定大鼠血浆中左旋紫堇达明(L-CDL)的浓度,经系统方法学验证后,应用于该药的大鼠药代动力学研究。方法以普萘洛尔为内标,以水(含0.1%甲酸与5 mmol/L的甲酸铵)和乙腈(含0.1%甲酸)为流动相,血浆样品中的L-CDL和内标经C18(2.1 mm×750 mm,3μm)柱分离后,质谱电喷雾离子化源(ESI)正离子多反应监测(MRM)方式分别对离子对m/z 342?192.1和m/z 260?116.2进行检测。方法验证包括专属性、标准曲线与定量下限、批内和批间精密度、准确度、基质效应、提取回收率、稳定性。结果 L-CDL在大鼠血浆样品的定量线性范围为1~5000 ng/ml,最低定量下限为1 ng/ml,批内和批间精密度(RSD)<10%,回收率93.5%~102.8%,基质效应108.3%~112.5%。大鼠经胃给予L-CDL 10 mg/kg后的主要药动学参数Cmax、T1/2、AUC0-24分别为:(557.8±330.1)ng/ml、(7.04±3.93)h、(2408±630)h·ng/ml。结论建立的LC-MS/MS方法简便、快速、灵敏,适用于L-CDL在大鼠体内的药代动力学研究。  相似文献   

18.
错配PCR致突变的实验条件研究   总被引:10,自引:0,他引:10  
目的:对目前常用的致突菌株和PCR随机突变方法进行评价。方法:用单链抗体表达质粒转化致突菌株XL1-Red,转种传代7d,选取克隆测定DNA序列。用错配PCR在相同基因中引入突变,比较不同Mg^2 浓度、不同dNTP的浓度、不同dITP等条件下所致突变率。结果:在XL1-Red菌株中转种7d(约50代)后,测定突变率<0.1%。在错配PCR中,增加Mg^2 浓度可提高突变率,增加dTTP和dCTP浓度的致突变效果优于增加dATP和dGTP的效果。在dITP配以低浓度的dATP或dGTP时突变率较低,使用5mmol/L MgCl2、0.5mmol/L MnCl2、1mmol/L dTTP和dCTP的条件下,经2轮PCR(共60个循环)突变率可>2%。其突变类型有明显偏向性,以A/T的突变为主,转移多于颠换。结论:用致突菌株引入的突变率过低,不适用于抗体亲和力成熟,错配PCR在合适条件下可达到2%以上突变率,适用于随机突变抗体库的构建,但其突变类型有偏向性,应予以考虑。  相似文献   

19.
ObjectiveTo develop a dressing with desired antibacterial activity, good water maintaining ability and mechanical properties for wound healing and skin regeneration. MethodsThe chitosan with different concentrations were added in keratin solution to form porous keratin/chitosan (KCS) scaffolds. The morphological characteristics, chemical composition, wettability, porosity, swelling ratio and degradation of the scaffolds were evaluated. The antibacterial activity was tested by usingS. aureusandE. colisuspension for 2 h. And L929 fibroblast cells culture was used to evaluate the cytotoxicity of the KCS scaffolds. ResultsThe adding of chitosan could increase the hydrophobicity, decrease porosity, swelling ratio and degradation rate of the KCS porous scaffolds.Mechanical properties of KCS scaffolds could be enhanced and well adjusted by chitosan. KCS scaffolds could obviously decrease bacteria number.The proliferation of fibroblast cells in porous KCS patch increased firstly and then decreased with the increase of chitosan concentration. It was appropriate to add 400 μg/mL chitosan to form porous KCS scaffold for achieving best cell attachment and proliferation compared with other samples. ConclusionThe porous KCS scaffold may be used as implanted scaffold materials forpromoting wound healing and skinregeneration.  相似文献   

20.
7.0T Micro MRI 观察丝裂霉素C预防硬膜外粘连的效果研究   总被引:2,自引:0,他引:2  
目的:应用7.0T Micro MRI探讨预防椎板切除后硬膜外粘连实验研究中丝裂霉素C(MMC)的理想浓度及其使用安全性。方法:30只SD大鼠随机分成5组,每组6只。分别切除L1椎板,术中各组分别以棉片浸透生理盐水(A组)或0.1mg/ml(B组)、0.3mg/ml(C组)、0.5mg/ml(D组)、0.7mg/ml(E组)的MMC,置于裸露的硬脊膜后5min。应用MMC前后分别对大鼠行体感诱发电位测定。术后4周处死大鼠取手术段脊柱,分别做MicroMRI扫描、瘢痕组织面积测定、肉眼观察硬脊膜与后方瘢痕组织粘连情况。结果:A组标本硬膜外瘢痕组织致密,瘢痕面积大,与硬脊膜形成紧密粘连。B组和C组标本硬膜外瘢痕组织不致密,瘢痕面积减小,与硬脊膜部分粘连。D组和E组标本硬膜外瘢痕组织不致密,瘢痕面积更小,与硬脊膜未形成明显粘连。大鼠应用MMC前后体感诱发电位无明显改变。结论:局部应用浓度为0.5mg/ml的MMC能有效减少硬膜外瘢痕组织增生,避免椎板切除术后硬膜外瘢痕粘连,并且安全。0.5mg/ml浓度的MMC可能是椎板切除后预防硬膜外粘连理想的浓度选择。  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号